Film creditsDetected. Measured. Different questions.
What analytical capability is actually needed for the next research decision?
Proposed research direction. External studies are attributed; no original VARUNÉ Bio analytical results or validated assay are claimed.
Which decision the limit serves
Ask which decision the limit serves.
The lowest reported concentration is not automatically the most useful analytical result. A development team may need to distinguish a change between preparations, estimate a marker amount or decide whether a more expensive comparison is warranted. Those decisions require different capability statements. This proposed chapter asks how detection, quantification and decision levels should be specified for a defined method and matrix. Its practical value is to prevent procurement based on an impressive isolated sensitivity figure when the buyer really needs reliable preparation, comparable units and an uncertainty small enough to resolve its particular question.
Examine the development decision
Detected. Measured. Different questions.
Open the sequence to examine what a development decision needs.
Identify the exact preparation, its source, and the properties a second laboratory must be able to reproduce.
Explanatory geometry · no simulated or measured performance
Keeping the concepts separate
Keep the concepts separate.
NIST’s account of Currie (1968) distinguishes a critical level used to assess an observation, detection capability of a measurement process, and a determination level linked to acceptable quantitative uncertainty. These concepts depend on the error structure and chosen false-positive and false-negative probabilities. They are not interchangeable labels for the smallest standard tested. A proposed study should state its operational definition before measurements begin. The original 1968 paper was not accessed in this review; the inspected NIST account supports the conceptual distinction, while the candidate experiment must establish its own actual response distributions.
The curve contributes uncertainty
The curve contributes uncertainty.
Converting a response to concentration relies on a fitted calibration with uncertain intercept, slope and residual behaviour. Near the blank, small changes in those quantities can dominate the inferred concentration. The local linear model shown here is therefore conditional, not a universal detection formula. Pilolli et al. (2023; issue 2024) include calibration and other contributions in their method uncertainty. A proposed comparison should examine the relevant low-concentration region with suitable controls, rather than assume that a wide-range fit or a familiar multiplier gives a defensible detection capability for every matrix.
Local linear response model; residuals and back-calculated controls decide suitability, rather than correlation alone.
- Measured analytical responseresponse units
- Intercept including residual backgroundresponse units
- Response sloperesponse units/(µg/mL)
- Named marker concentration in measured solutionµg/mL
Model conditions. Only a verified local calibration range. Independent controls assess bias; linearity and constant variance are not presumed.
A signal that survives the question.
Define the marker, matrix and measurement that could change an ingredient or materials development decision.
Read published limits in context
Read published limits in context.
Svigelj et al. (2022) report a detection calculation for their ECL aptasensor; Xie et al. (2024) use their own operational blank-based definition for competitive ELISA. Those figures belong to different response mechanisms, preparation designs and reporting bases. Ranking them without reconciling those conditions would be misleading. The candidate programme would retain each study’s definition and inspected scope in the evidence record. It would not advertise an external limit as Bio performance, convert a solution limit to a food mass fraction without preparation factors, or infer detection of every milk component from one marker.
Examine the comparison
| Concept | Question | Basis |
|---|---|---|
| Decision level | How is an observed response assessed? | Specified error model and false-positive control |
| Detection capability | What signal can the process reliably detect? | Specified false-positive/false-negative assumptions |
| Quantification capability | What amount can be reported with acceptable uncertainty? | Bias, precision, calibration and reporting basis |
Change the conditions · examine the reference
Sensitivity starts with the comparison.
Change calibration slope and response variation. Keep the estimate separate from a validated analytical capability.
The data, equations and controls remain available below if 3D cannot load.
Defined model · illustrative conditions
Move a control to compare the selected condition with the defined reference curve.
Specify blank, matrix and low-level precision comparisons before discussing method capability.
The defined comparison
Linear-response estimates for a hypothetical concentration scale in μg L⁻¹. No analyte, matrix or actual calibration is represented. Slope is positive; response SD is a chosen input. Low-level performance, specificity, recovery, matrix effects and precision require a qualified validation study. The displayed curve is not measured sensitivity or a limit of detection achieved by VARUNÉ.
Inspect the calculated values
Calculation grid, not measured observations. Inputs and assumptions are stated above.
| Calibration slope / AU per μg L⁻¹ | Detection estimate | Quantitation estimate |
|---|
Blank behaviour deserves its own study
Blank behaviour deserves its own study.
A buffer blank can underestimate the variability of a processed matrix blank. Different extraction days, operators or lots may contribute additional background. A proposed method capability check should therefore identify the blank population, independent preparation count and treatment of outlying or censored values. Negative readings after subtraction do not justify truncating everything to zero before assessing variability. The analysis needs a response scale on which the error model is credible. If distributions are non-normal or concentration-dependent, the decision procedure must accommodate that behaviour rather than force it into an attractive textbook approximation.
Quantification needs acceptable error
Quantification needs acceptable error.
A measurable signal may still yield a concentration with uncertainty too large for the intended comparison. The proposed quantification requirement should be tied to a pre-agreed level of bias and precision at the decision interval. This is a research acceptance criterion, not a food-safety threshold or a clinical dose. An ingredient customer comparing lots might need a relative change resolved consistently; an assay developer may first need proof that matrix load does not distort the curve. Neither decision is answered merely by showing that a detector responds to a very small amount in clean solution.
Design an interpretable first experiment
Design an interpretable first experiment.
The first capability study would use a qualified method, representative blanks, independently prepared positive controls and a documented calibration range. It should ask whether the error structure can be estimated with available resources before promising an extensive validation programme. If the blank varies strongly or low-level controls cannot be prepared traceably, the next useful investment may be sample preparation or reference material, not further signal amplification. Resources, quotations and responsibility for the statistical plan would be agreed before laboratory work. No numerical threshold or validated sensitivity is asserted for the proposed Bio programme.
The next proposed comparison.
An honest capability statement
An honest capability statement
An honest capability statement.
The proposed deliverable would name the method, marker, matrix, preparation and response scale, then distinguish qualitative recognition from quantitative reporting. It would record the decision rule, uncertainty assumptions, experimental units and evidence supporting the stated range. A potential research customer could then assess whether the capability resolves its development question and what additional work is needed. This statement should make unsuccessful or ambiguous results visible, because those results can prevent an unsuitable product claim. The next discussion is about a funded, bounded capability assessment, with food release, clinical decisions and consumer safety explicitly outside its purpose.
Analytical detection · Proposed development discussion
A development path
for this research.
What analytical capability is actually needed for the next research decision?
The people this could serve.Research and analytical development teams.
The decision behind the project.
Your intended application, present alternative and the constraint behind “Detection, quantification and decision levels”. A useful starting point is the change that would justify another development step.
A proposed scope centred on an honest capability statement.
Agree the comparison, acceptance basis and responsible expertise before discussing a paid package.
Specialist methods and a defined contribution.
Bring relevant analytical or experimental expertise, a comparator suggestion, and the conditions under which your method could resolve this question.
A jointly scoped proposal could connect your contribution with an honest capability statement.
Define contributions, required access, independent preparations and permitted outputs before work or protected information is shared.
The commercial purpose of the next milestone.
Bring the application or asset thesis, the buyer you expect to value it, and the scientific or commercial uncertainty that must be resolved before another commitment.
The proposed decision record would connect the buyer question with an honest capability statement. It would identify what a subsequent comparison needs to demonstrate.
Demand, development cost, resources, rights and a decision-changing milestone would need examination. No financing terms or investment outcome are represented here.
What a useful comparison
would record.
- Retain individual calibrants, blanks and the response range on a declared concentration basis.
- Record independent preparations separately from repeated instrument readings.
- Assess recovery, residuals and limits within the matrix and range actually studied.
What the proposed
brief could leave behind.
- An honest capability statement
- A preparation, comparator and endpoint record tied to this question.
- A source-linked account of the evidence gaps, study assumptions and next review point.
The proposed discussion brief
A brief you
can take away.
Use non-confidential notes to connect this topic with your own decision. Entries stay in this browser tab; saving creates a text file on your device. Nothing is submitted.
Potential scoped analytical feasibility or method-comparison discussion
Notes are optional. The brief includes this page’s proposed question and public source links.
Proposed scope; resources, methods, rights and delivery terms would be agreed before work. Begin with non-confidential information.
Sources and reading notes.
External work is identified below. Access notes describe the material inspected for this page; company research questions and proposed work are not presented as findings from these sources.
Pilolli et al, 2023Pilolli et al. (2023; issue 2024). In-house validation of an LC–MS method for the multiplexed quantitative determination of total allergenic food in chocolate
Chocolate preparation, marker conversion, matrix-matched calibration, independent preparation versus instrumental replicates.
Scope and limitations: External research in the authors’ stated preparations and conditions. No VARUNÉ Bio results, rights, laboratory capacity or analytical validation established. No figure or dataset is reproduced here.
Open original sourceSvigelj et al, 2022Svigelj et al. (2022). A portable electrochemiluminescence aptasensor for β-lactoglobulin detection
Aptamer immobilisation, blocking, ECL transduction and matrix-specific sample handling.
Scope and limitations: External research in the authors’ stated preparations and conditions. No VARUNÉ Bio results, rights, laboratory capacity or analytical validation established. No figure or dataset is reproduced here.
Open original sourceXie et al, 2024Xie et al. (2024). Development of an Indirect Competitive ELISA Based on a Stable Epitope of β-Lactoglobulin for Its Detection in Hydrolyzed Formula Milk Powder
Epitope-dependent response, competitive assay, processed proteins, analytical comparator limitations.
Scope and limitations: External research in the authors’ stated preparations and conditions. No VARUNÉ Bio results, rights, laboratory capacity or analytical validation established. No figure or dataset is reproduced here.
Open original sourceNIST/SEMATECH, n.d.Lindstrom, NIST. Limits for Qualitative Detection and Quantitative Determination: account of Currie (1968)
Decision level, detection capability, quantification precision and explicit α/β assumptions.
Scope and limitations: Secondary account is not counted toward three primary studies. No universal numerical LOD rule adopted.
Open original source